Latest Parkinson's disease Stories
REHOVOT, Israel, October 23, 2014 /PRNewswire/ -- NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today
The Parkinson Alliance Reports Findings Pertaining to Autonomic Dysfunction in Parkinson's KINGSTON, N.J., Oct.
COLUMBUS, Ohio, Oct.
In its thirty-six year history, the American Parkinson Disease Association Cozias Fellowship has been awarded to only twenty-eight scientific investigators New
Sales of a Novel Antipsychotic and an Improved Rescue Therapy Will Contribute Approximately $1 Billion to the PD Market in 2023, According to Findings from Decision Resources Group BURLINGTON,
Allied Team Training for Parkinson's Disease will be held in San Diego, CA this November MIAMI, Oct.
Robust Clinical Development Programs Across Sellas' Portfolio of Drugs and Biologics ZUG, Switzerland and NEW YORK, Oct.
Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy is a new OT PT Continuing Education courses designed to deliver new rehab information on the treatment
The American Parkinson Disease Association has announced $1.1 million in new research funding for 2014-2015 supporting seven Research grants, three Post-Doctoral Fellowships, and eight Centers
- totally perplexed and mixed up.
More Images (1 images) »